1Mutch DG, Soper JT, Budwit-Novotny DA, et al. Endometrial adenocarcinoma estrogen receptor content: association of clinicopathologic features with immunohistochemical analysis compared with standard biochemical methods[J]. AM J Obstet Gynecol, 1987,157(4) : 924-931.
2Kuerer HM, Single tary SE, Buzdar AU,et al. Suegical conservation planning after neoadjuvant chemotherapy for stage Ⅱ and operable stage Ⅲ breast carcinoma[J]. AM J Surg, 2001,182:601-608.
